Meta‐analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding

  title={Meta‐analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding},
  author={Y Bai and J-F Guo and Z-S Li},
  journal={Alimentary Pharmacology \& Therapeutics},
Aliment Pharmacol Ther 2011; 34: 166–171 

Paper Mentions

Interventional Clinical Trial
The goal of this study is to determine whether use of promotility agents to stimulate gastric peristalsis can reduce fluoroscopy time and procedure time during gastrojejunostomy (GJ… Expand
ConditionsEnteral Nutrition, Radiation Exposure
Multidisciplinary management strategies for acute non‐variceal upper gastrointestinal bleeding
The modern management of acute non‐variceal upper gastrointestinal bleeding is centred on endoscopy, with recourse to interventional radiology and surgery in refractory cases. The appropriate use ofExpand
Approach to acute upper gastrointestinal bleeding in adults
The initial evaluation of patients with acute upper GI bleeding involves an assessment of hemodynamic stability and resuscitation if necessary, and diagnostic studies follow, with the goal of both diagnosis, and when possible, treatment of the specific disorder. Expand
Upper endoscopy in liver disease
Watch a video presentation of this article: The next generation of smart phones will be able to recognise each other's voices and provide real-time information about the person they are communicating with. Expand
Management of non variceal upper gastrointestinal bleeding: Position paper statement of the Catalan Society of Gastroenterology
This document of the Catalan Society of Digestologia is an update of evidence-based recommendations on management of gastrointestinal bleeding peptic ulcer. Expand
What Medications Are Helpful in Treating a GIB?
Pre-endoscopic pharmacologic therapy can decrease the amount of bleeding and thereby assist in achieving hemostasis in patients with gastrointestinal bleeding. Expand
Management of Non Variceal Upper Gastrointestinal Bleed
Adopting a system which identifies severe bleeding and vulnerable patients is essential and early endoscopic management of severe upper GI bleeds improves survival. Expand
The pharmacological therapy of non-variceal upper gastrointestinal bleeding.
The available data on the use of antisecretory regimens in the management of patients with bleeding peptic ulcers are discussed, which are a major cause of non-variceal upper gastrointestinal bleeding. Expand
Upper gastrointestinal haemorrhage
Upper gastrointestinal (UGI) haemorrhage is bleeding from any point of the GI tract proximal to the ligament of Treitz, and the gold standard investigation for diagnosis is endoscopy, which can facilitate certain therapeutic interventions. Expand
Endoscopic therapy of non-variceal upper gastrointestinal bleeding
Upper GI bleeding (UGIB) is a common cause of hospitalization. Non-variceal upper GI bleeding, comprise multiple causes of which peptic ulcer is the most common. The treatment of patients with UGIBExpand
Role of Medical Therapy for Nonvariceal Upper Gastrointestinal Bleeding.
Current evidence-based recommendations for the medical management of nonvariceal upper gastrointestinal bleeding are presented and the use of postendoscopic intravenous proton pump inhibitors is strongly recommended for certain patient populations. Expand


Prokinetics in acute upper GI bleeding: a meta-analysis.
Intravenous erythromycin or metoclopramide immediately before EGD in acute UGIB patients decreases the need for a repeat EGD, but does not improve other clinically relevant measurable outcomes. Expand
Acute nonvariceal upper gastrointestinal bleeding
Endoscopic therapy remained the mainstay of ulcer hemostasis and high dose proton pump inhibitor infusion should be employed to prevent rebleeding and patients categorized as low risk may be managed as outpatients. Expand
Erythromycin Infusion Prior to Endoscopy for Acute Upper Gastrointestinal Bleeding: A Randomized, Controlled, Double-Blind Trial
Intravenous erythromycin before endoscopy improves stomach cleansing and quality of endoscopic examination in patients with upper gastrointestinal bleeding, but the clinical benefit is limited. Expand
Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial.
Erythromycin infusion before endoscopeopy in patients with recent hematemesis makes endoscopy shorter and easier, thereby reducing the need for a repeat procedure. Expand
Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study.
In patients with acute upper GI bleeding, infusion of erythromycin before endoscopy significantly improved the quality of EGD and tended to reduce the need for second-look endoscopic. Expand
Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
Data published since 1997 suggest that mortality in patients suffering from an upper gastrointestinal bleed or perforation has fallen to 1 in 13 overall, but remains higher at about 1 in 5 in those exposed to NSAID or aspirin. Expand
Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study.
  • G. Longstreth
  • Medicine
  • The American journal of gastroenterology
  • 1995
The annual incidence of hospitalization for AUGIH was 102.0 per 100,000, increased markedly with age, and was twice as high in males as in females and older age, female gender, and NSAID use. Expand
The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
It is concluded that in view of the growing weight of evidence demonstrating the potential epidemiological impact of the increased use of macrolides upon the spread of resistance, versus a lack of sufficient and convincing evidence that erythromycin A is a superior prokinetic agent to potential alternatives in the critically ill patient population, at this stage it is not recommended to advocate the use of erynonymous A as a prokinetics agent in critically ill patients unless they have failed all other treatment. Expand
Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trial.
Erythromycin infusion before endoscopeopy in patients with variceal bleeding significantly improves endoscopic visibility and shortens the duration of the index endoscopy. Expand
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
Recommendations emphasize early risk stratification, by using validated prognostic scales, and early endoscopy, whereas data support attempts to dislodge clots with hemostatic, pharmacologic, or combination treatment of the underlying stigmata. Expand